4.6 Article

A potential model of systemic sclerosis with pulmonary hypertension induced by monocrotaline plus bleomycin

Related references

Note: Only part of the references are listed.
Review Medicine, General & Internal

Circulating Blood-Based Biomarkers in Pulmonary Hypertension

Marta Banaszkiewicz et al.

Summary: Pulmonary hypertension is a serious hemodynamic condition that can lead to right heart failure and death if not properly treated. The prognosis of pulmonary hypertension depends on various factors, and biomarkers provide information about disease severity, treatment response, and prognosis. However, due to the complexity of the condition, a single biomarker is not sufficient for evaluating different types of pulmonary hypertension patients.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Cell Biology

Mirodenafil ameliorates skin fibrosis in bleomycin-induced mouse model of systemic sclerosis

Jong Seong Roh et al.

Summary: The study revealed that mirodenafil has the potential to alleviate skin fibrosis caused by SSc by downregulating the TGF-β/Smad signaling pathway.

ANIMAL CELLS AND SYSTEMS (2021)

Article Biochemistry & Molecular Biology

SMAD4 Feedback Activates the Canonical TGF-β Family Signaling Pathways

Lu Liu et al.

Summary: The study illustrates a novel mechanism in which SMAD4, as the only Co-SMAD, positively regulates the canonical TGF-beta family signaling pathways in granulosa cells (GCs) by interacting with the core promoters of upstream receptors through the recruitment of three coactivators (c-JUN, CREB1, and SP1). Different interaction modes between SMAD4 and coactivators were identified through reciprocal ChIP assays, expanding the understanding of the feedback regulation modes of TGF-beta family signaling pathways in ovarian GCs.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Respiratory System

Pulmonary hypertension in systemic sclerosis: diagnosis by systematic screening and prognosis after three years follow-up

Veronica Silva Vilela et al.

Summary: Systematic screening in a Brazilian population identified systemic sclerosis pulmonary hypertension (SSc-PH) patients with severe clinical and hemodynamic features. Mortality remains high in SSc-PH, more related to Bo-PAH and SSc-ILD-PH, while the prognosis of systemic sclerosis pulmonary arterial hypertension (SSc-PAH) was better.

BMC PULMONARY MEDICINE (2021)

Review Medicine, General & Internal

Systemic Sclerosis-Associated Pulmonary Hypertension: Spectrum and Impact

Mario Naranjo et al.

Summary: Systemic sclerosis-associated pulmonary arterial hypertension (SSc-PAH) is a catastrophic complication of autoimmune diseases, causing high mortality rates among patients. Despite advancements in screening methods and therapies, improved outcomes are still needed, urging the search for innovative treatment options.

DIAGNOSTICS (2021)

Review Medicine, General & Internal

Pathophysiology of systemic sclerosis

Benjamin Thoreau et al.

Summary: Systemic sclerosis is a rare connective tissue disease characterized by vascular remodeling, fibroblast activation, and excess extracellular matrix production, influenced by genetic and environmental factors. Research has shown that immune activation and fibrosis processes involve various cellular and molecular factors, leading to the exploration of new therapeutic approaches.

PRESSE MEDICALE (2021)

Article Medicine, Research & Experimental

Polydatin prevents bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β/Smad/ERK signaling pathway

Yan-Lu Liu et al.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2020)

Review Biochemistry & Molecular Biology

Specificity, versatility, and control of TGF-β family signaling

Rik Derynck et al.

SCIENCE SIGNALING (2019)

Review Health Care Sciences & Services

Therapeutic Challenges And Advances In The Management Of Systemic Sclerosis-Related Pulmonary Arterial Hypertension (SSc-PAH)

Rahul G. Argula et al.

THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2019)

Article Respiratory System

Low dose monocrotaline causes a selective pulmonary vascular lesion in male and female pneumonectomized rats

Daniel J. Lachant et al.

EXPERIMENTAL LUNG RESEARCH (2018)

Review Medicine, General & Internal

Pulmonary arterial hypertension: pathogenesis and clinical management

Thenappan Thenappan et al.

BMJ-BRITISH MEDICAL JOURNAL (2018)

Review Medicine, General & Internal

Pulmonary arterial hypertension: pathogenesis and clinical management

Thenappan Thenappan et al.

BMJ-BRITISH MEDICAL JOURNAL (2018)

Article Biochemistry & Molecular Biology

Leflunomide prevents ROS-induced systemic fibrosis in mice

Florence Morin et al.

FREE RADICAL BIOLOGY AND MEDICINE (2017)

Review Rheumatology

Pulmonary hypertension in connective tissue diseases: an update

Ramya Aithala et al.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2017)

Article Cardiac & Cardiovascular Systems

Monocrotaline Induces Endothelial Injury and Pulmonary Hypertension by Targeting the Extracellular Calcium-Sensing Receptor

Rui Xiao et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)

Review Respiratory System

Pulmonary hypertension in systemic sclerosis: different phenotypes

David Launay et al.

EUROPEAN RESPIRATORY REVIEW (2017)

Article Respiratory System

Role of interleukin-1 receptor 1/MyD88 signalling in the development and progression of pulmonary hypertension

Aurelien Parpaleix et al.

EUROPEAN RESPIRATORY JOURNAL (2016)

Article Pharmacology & Pharmacy

Exploring the monocrotaline animal model for the study of pulmonary arterial hypertension: A network approach

Rita Nogueira-Ferreira et al.

PULMONARY PHARMACOLOGY & THERAPEUTICS (2015)

Article Physiology

The monocrotaline model of pulmonary hypertension in perspective

Jose G. Gomez-Arroyo et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2012)

Review Physiology

Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure

Kurt R. Stenmark et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2009)

Article Critical Care Medicine

Connective Tissue Disease-associated Pulmonary Arterial Hypertension in the Modern Treatment Era

Robin Condliffe et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)

Article Respiratory System

An epidemiological study of pulmonary arterial hypertension

A. J. Peacock et al.

EUROPEAN RESPIRATORY JOURNAL (2007)